MDWD $1.60 -Good news + FDA decision in 13 days MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma https://finance.yahoo.com/news/mediwound-announces-positive-results-u-120000541.html